Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via Google Scholar Articles by Chang, G. Articles by Antin, J. H. Search for Related Content PubMed Citation Articles by Chang, G. Articles by Antin, J. H. Syndromes Secondary to General Medical Disorders

Predictors of 1-Year Survival Assessed at the Time of Bone Marrow Transplantation

Received May 22, 2003; revision received Nov. 17, 2003; accepted Dec. 16, 2003. From Brigham and Women's Hospital; the Department of Psychiatry, the Department of Medicine, and the Department of Medicine (Biostatistics), Harvard Medical School, Boston; and the Dana Farber Cancer Institute, Boston. Address correspondence to Dr. Chang, Brigham and Women's Hospital, 221 Longwood Ave., Boston, MA 02115; Gchang{at}partners.org (e-mail).

The purpose of this prospective cohort study was to identify pretransplant and transplant predictors of 1-year survival after allogeneic hematopoietic stem cell transplantation (HSCT) for chronic myelogenous leukemia. Psychosocial and behavioral variables such as alcohol abuse and cigarette smoking were systematically assessed at the time of HSCT with structured diagnostic instruments. A total of 114 patients participated, with an overall 1-year survival rate of 66%. Lifetime alcohol and other substance use, cigarette smoking, depression, and quality of life prior to transplant were not found to affect 1-year survival. However, other clinical variables prior to transplant and once transplant occurred were found to predict survival.

Get information about faster international access.

Privacy Policy

Copyright © 2004 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us